COMBINATION ANTI-CANCER AGENTS
First Claim
Patent Images
1. A method of treating cancer in a mammal comprising:
- administering Lucanthone to the mammal; and
administering at least one anti-metabolite to the mammal,wherein said Lucanthone and said at least one anti-metabolite are administered in therapeutically effective amounts.
1 Assignment
0 Petitions
Accused Products
Abstract
The present disclosure relates to methods of treating cancer in mammals by administration of Lucanthone and at least one anti-metabolite. Pharmaceutical compositions and kits comprising Lucanthone and at least one anti-metabolite also are disclosed.
4 Citations
20 Claims
-
1. A method of treating cancer in a mammal comprising:
-
administering Lucanthone to the mammal; and administering at least one anti-metabolite to the mammal, wherein said Lucanthone and said at least one anti-metabolite are administered in therapeutically effective amounts. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)
-
-
19. A pharmaceutical composition comprising therapeutically effective amounts of Lucanthone and at least one anti-metabolite, and a pharmaceutically acceptable carrier.
-
20. A pharmaceutical kit comprising:
-
a pharmaceutical composition comprising a therapeutically effective amount of Lucanthone and a pharmaceutically acceptable carrier, and a pharmaceutical composition comprising a therapeutically effective amount of at least one anti-metabolite and a pharmaceutically acceptable carrier.
-
Specification